UNOS政策变更对心脏移植术后排斥反应、感染及再住院率的影响
该研究基于UNOS注册数据,比较政策变更前(2016年11月1日至2017年10月31日移植)与变更后(2018年11月1日至2019年10月31日移植)成人单纯心脏移植受者,采用多因素逻辑回归分析政策变更对术后排斥、感染和再住院的影响,并纳入两个COVID-19时期。结果显示治疗性排斥、再住院、排斥所致再住院及感染所致再住院的比值在政策前后相似,排斥比值有下降趋势。
要点
- 政策变更前后治疗性排斥、再住院、排斥及感染所致再住院的比值相似。
- 排斥比值在政策变更后呈下降趋势(p=0.08)。
- 两个COVID-19时期排斥及治疗性排斥均减少,全因再住院比值增加。
核心结论
- UNOS政策变更改善了高危患者接受心脏移植的可及性,且未增加术后早期治疗性排斥或排斥、感染所致再住院率。
研究设计与样本
- 回顾性队列研究,纳入UNOS注册库中所有成人单纯心脏移植受者,政策前组为2016年11月1日至2017年10月31日移植者,政策后组为2018年11月1日至2019年10月31日移植者,采用多因素逻辑回归分析,并纳入2019-2020和2020-2021两个COVID-19时期。
主要发现
- 治疗性排斥(p=0.8)、再住院(p=0.69)、排斥所致再住院(p=0.76)及感染所致再住院(p=0.66)的比值在政策前后相似。
- 排斥比值在政策变更后呈下降趋势(p=0.08)。
- 在两个COVID-19时期,排斥和治疗性排斥均明显减少,排斥或感染所致再住院无影响。
- 在两个COVID-19时期,全因再住院比值均增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The 2018 adult heart allocation policy sought to improve waitlist risk stratification, reduce waitlist mortality, and increase organ access. This system prioritized patients at greatest risk for waitlist mortality, especially individuals requiring temporary mechanical circulatory support (tMCS). Posttransplant complications are significantly higher in patients on tMCS before transplantation, and early posttransplant complications impact long-term mortality. We sought to determine if policy change affected early posttransplant complication rates of rejection, infection, and hospitalization. METHODS: We included all adult, heart-only, single-organ heart transplant recipients from the UNOS registry with pre-policy (PRE) individuals transplanted between November 1, 2016, and October 31, 2017, and post-policy (POST) between November 1, 2018, and October 31, 2019. We used a multivariable logistic regression analysis to assess the effect of policy change on posttransplant rejection, infection, and hospitalization. Two COVID-19 eras (2019-2020, 2020-2021) were included in our analysis. RESULTS: The majority of baseline characteristics were comparable between PRE and POST era recipients. The odds of treated rejection (p = 0.8), hospitalization (p = 0.69), and hospitalization due to rejection (p = 0.76) and infection (p = 0.66) were similar between PRE and POST eras; there was a trend towards reduced odds of rejection (p = 0.08). In both COVID eras, there was a clear reduction in rejection and treated rejection with no effect on hospitalization for rejection or infection. Odds of all-cause hospitalization was increased in both COVID eras. CONCLUSIONS: The UNOS policy change improves access to heart transplantation for higher acuity patients without increasing early posttransplant rates of treated rejection or hospitalization for rejection or infection, factors which portend risk for long-term posttransplant mortality.
引用
- Vaidya AS, Lee ES, Kawaguchi ES, et al. Effect of the UNOS policy change on rates of rejection, infection, and hospital readmission following heart transplantation. J Heart Lung Transplant. 2023. PMID: 37211332. doi:10.1016/j.healun.2023.05.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。